Work Area: Transactions

Latest content

Pfizer to commercialise its IP with the help of trailblazing Roivant approach

The partnership is aimed at helping the pharma giant to moentise deprioritised IP in the autoimmune space

04 July 2022

Data monetisation gathers momentum in the healthcare sector

Life sciences innovators are increasingly paying for access to high-quality data

27 June 2022

BlackBerry CEO “responding to the calls” of other bidders for the company’s patents

John Chen says there’s a high probability that Catapult IP Innovations will still buy the portfolio, but he wants shareholders to know he’s “not just stuck with one option”

24 June 2022

Change at the top of Xiaomi’s IP Strategy team

After six years in charge, Paul Lin steps down to go solo, although he will remain an adviser to the Chinese company

23 June 2022

Why IP valuation in Asia has yet to take off

Although various government-led programmes have emerged over the years to encourage activity in the field, writes Joyce Ng, professionals reveal that a lack of transaction data and an absence of corporate buy-in is preventing it from going mainstream

22 June 2022

New IP finance play, Ukraine tribute, patent litigation trends and plenty more as IPBC Global 2022 comes to an end

Despite the close attentions of a tornado and the deadening heatwave that preceded and followed it, delegates and speakers in Chicago were in good form for the final day of this year's event

15 June 2022

Nokia strikes deal to commercialise non-core, cooling technology IP

Collaboration with Innventure is the latest attempt to realise the value of innovations outside the company's strategic focus

14 June 2022

Patent transactions in Q1 2022

Featured in Secondary Market Activity

Latest data from AST points to a steep decline from the previous year’s numbers, but there are some indications that more licensing is being done

08 June 2022

GSK’s $3.3 billion buyout shows vaccine IP boom goes beyond mRNA

Affinivax acquisition based on platform tech licensed from Boston Children’s Hospital

06 June 2022

AT&T’s billion dollar secret sauce

Scott Frank, President and CEO of the company’s IP operation, reveals how its team of patent developers takes a venture capital approach to interactions with inventors and lawyers to ensure the development of a highly diversified, revenue-generating, portfolio of rights

01 June 2022

Unlock unlimited access to all IAM content